Bioimplant with evanescent coating film
To provide a bioimplant capable of controlling a rate of an antibacterial agent and an antibiotic to be eluted from the coating film. An evanescent coating film made of a calcium phosphate-based material having crystallinity of 90% or less is formed at a predetermined area of the bioimplant and an antibacterial agent or an antibiotic is contained in the coating film. If necessary, a metal oxide layer made of a metal oxide having an isoelectric point of less than 7 is formed on the bioimplant thereby suppressing adhesion of bacteria.
1. A bioimplant comprising:
an implant comprising a metal or metal alloy material; and
an evanescent coating film comprising a calcium phosphate-based material having crystallinity of 10% to 90%, the evanescent coating film containing an inorganic antibacterial agent,
wherein the inorganic antibacterial agent comprises silver metal or silver oxide,
wherein the evanescent coating film is free of any oxide of the metal or metal alloy material except the calcium phosphate-based material and the inorganic antibacterial agent, and
wherein a thickness of the evanescent coating film is between 5 and 100 micrometers (μm).
2. The bioimplant according to claim 1 , wherein the inorganic antibacterial agent comprises silver metal particles distributed in the evanescent coating film.
3. The bioimplant according to claim 1 , wherein the calcium phosphate-based material comprising at least one material selected from the group consisting of: hydroxyapatite (HA), tertiary calcium phosphate (TCP) and quaternary calcium phosphate (TeCP).
4. The bioimplant according to claim 1 , wherein the thickness of the evanescent coating film is between 20 and 100 micrometers (μm).
5. The bioimplant according to claim 1 , wherein an elution period of the inorganic antibacterial agent when the implant is placed in a body fluid is at least six months.
6. The bioimplant according to claim 1 , wherein the implant comprises a metal or metal alloy material.
7. The bioimplant according to claim 1 , wherein the evanescent coating film is formed on the implant by a thermal spraying method.
8. The bioimplant according to claim 7 , wherein the thermal spraying method is selected from a group consisting of a flame spraying, a high velocity oxygen fuel spraying, and a plasma spraying method.
9. A bioimplant for an artificial joint comprising:
an implant; and
an evanescent coating film formed on a surface of the implant by a thermal spraying method, wherein the evanescent coating film comprises:
a calcium phosphate-based material having a crystallinity of 10% to 90%
and
an inorganic antibacterial agent comprising a silver metal, silver oxide, or a combination thereof, wherein a thickness of the evanescent coating film is between 5 and 100 micrometers (μm) and wherein an evanescence period of the evanescent coating film is at least six weeks when the implant is placed in a body fluid.
10. The bioimplant according to claim 9 , wherein the evanescent coating film is directly formed on the implant or on a non-evanescent calcium phosphate coating formed on the implant.
11. The bioimplant according to claim 9 , wherein the calcium phosphate-based material comprises at least one material selected from the group consisting of hydroxyapatite (HA), tertiary calcium phosphate (TCP) and quaternary calcium phosphate (TeCP).
12. The bioimplant according to claim 9 , wherein the implant comprises a metal or metal alloy material and the evanescent coating film is free of any oxide of the metal or metal alloy material.
13. The bioimplant according to claim 9 , wherein the thermal spraying method is selected from the group consisting of a flame spraying, high velocity oxygen fuel spraying, and plasma spraying method.
14. A bioimplant, comprising:
an implant comprising a metal or metal alloy material; and an evanescent coating film formed on the implant by thermal spraying, wherein the evanescent coating film comprises a calcium phosphate-based material having a crystallinity of 10% to 90%, said calcium phosphate-based material being mixed with an inorganic antibacterial agent such that inorganic antibacterial agent particles are distributed in the coating, wherein the evanescent coating film is free of any oxide of the metal or metal alloy material and is directly formed on a surface of the implant or on a non-evanescent calcium phosphate coating formed on the implant surface, and
wherein a thickness of the evanescent coating film is between 5 and 100 micrometers (pm) and an evanescence period of the evanescent coating film is at least six weeks when the implant is placed in a body fluid.
15. The implant of claim 14 , wherein the inorganic antibacterial agent particles comprise silver metal particles.
16. The implant of claim 14 , wherein the inorganic antibacterial agent particles comprise silver oxide particles.
17. The implant of claim 14 , wherein the evanescent coating film has an evanescence period of at least three months when the implant is placed in a body fluid.
18. The implant of claim 14 , wherein the calcium-phosphate-based material comprises hydroxyapatite, β-tertiary calcium phosphate, or a mixture of both.
19. The implant of claim 14 , wherein a thickness of the evanescent coating film is 20 pm to less than 40 μm.
20. The implant of claim 14 , wherein a thickness of the evanescent coating film is 40 μm to less than 100 μm.